VXRT (Vaxart) Notes Receivable: $ Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

VXRT Vaxart Inc VXRT
49 GF Score
Price $0.47
! 3 Warning Signs
View Full Analysis

What is Vaxart Notes Receivable?

Vaxart VXRT -3.66% 49 Notes Receivable is $ Mil as of Jun. 2026. GuruFocus rates VXRT with a GF Score™ of 49/100. The stock has 3 warning signs investors should review.

Vaxart's Notes Receivable for the quarter that ended in Jun. 2026 was $ Mil.

Vaxart Notes Receivable Historical Data

* Premium members only.

The historical data trend for Vaxart's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vaxart Notes Receivable Chart

Vaxart Annual Data
Trend Jun16 Jun17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Vaxart Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -
VXRT
49GF Score
Vaxart Inc VXRT
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vaxart Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of $ Mil mean?
Vaxart (VXRT) has a Notes Receivable of $ Mil as of Jun. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Vaxart and its competitors.
Is Vaxart's Notes Receivable too high?
Vaxart's current Notes Receivable is $ Mil. Overall, Vaxart has a GF Score™ of 49/100, reflecting its overall financial health beyond just this single metric.
How does Vaxart's Notes Receivable compare to ENGN and NTHI?
Vaxart's Notes Receivable of $ Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Biotechnology company?
A good Notes Receivable depends on the Biotechnology industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Vaxart and its competitors. Vaxart's current Notes Receivable is $ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vaxart stock overvalued right now?
Vaxart (VXRT) has a current Notes Receivable of $ Mil. The current Notes Receivable is $ Mil. Vaxart's overall GF Score™ is 49/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Vaxart (VXRT), the current Notes Receivable is $ Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vaxart Business Description

Address 170 Harbor Way, Suite 300, South San Francisco, CA, USA, 94080
Vaxart Inc. is a clinical-stage biotechnology company based in the United States that develops oral recombinant vaccines delivered in tablet form rather than by injection. Its vaccines are built on a proprietary vector-adjuvant-antigen platform that uses a modified adenovirus vector to elicit immune responses in the gastrointestinal tract and systemically. The company's development pipeline targets infectious diseases including norovirus, seasonal influenza, respiratory syncytial virus (RSV), human papillomavirus (HPV), and coronaviruses, with norovirus and coronavirus programs among its most advanced. Vaxart also develops a proprietary oral vaccine adjuvant and has explored tablet vaccine formulations intended to be room-temperature stable and self-administered. The company operates in a single reporting segment, the discovery and development of oral recombinant vaccines, and conducts its activities primarily in the United States. As a clinical-stage business, it has no approved products and generates no product revenue, funding operations through equity offerings, grants, and collaboration agreements.
49GF Score

Get the complete analysis for VXRT

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.47
Price